Conversely, other studies suggest that HER2+ breast cancer lines that carry the PI3KCA mutation, leading to an overactive mTOR complex, show increased phosphorylation of the acetyl CoA synthetic enzyme, ATP citrate lyase (ACYL), via mTORC2 phosphorylation. Here, ERBB2 is linked to breast carcinoma.